Shares of Vertex Pharmaceuticals (VRTX -11.91%) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. The sharp decline came after the company announced its 2025 first-quarter results on Monday evening.Vertex reported Q1 revenue of $2.77 billion, up 3$1.24 billion, or $4.76 per share, up from$1.05 billion, or $4.06 per share, in the prior-year period. However, both top- and bottom-line numbers missed the consensus Wall Street estimates. In addition, Vertex reve ...